Site of ATP and phenylephrine synergistic stimulation of vasopressin release from the hypothalamo-neurohypophyseal system

Journal of Neuroendocrinology

Volumn 18, Issue 4, 2006, Pages 266-272

  Song, Zhilin ^a   Sladek, C D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

NE; Neural lobe; Supraoptic nucleus; Synergistic; Vasopressin

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA METHYL 4 CARBOXYPHENYLGLYCINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; METABOTROPIC RECEPTOR ANTAGONIST; PHENYLEPHRINE; TETRODOTOXIN; VASOPRESSIN;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; GLIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NERVE CELL; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; STATISTICAL ANALYSIS; VASOPRESSIN RELEASE;

ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; ARGININE VASOPRESSIN; DRUG SYNERGISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NEURAL PATHWAYS; ORGAN CULTURE TECHNIQUES; PHENYLEPHRINE; PITUITARY GLAND, POSTERIOR; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC;

EID: 33644644305     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2006.01411.x     Document Type: Article

References (32)

1. Kapoor JR, Sladek CD. Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release. J Neurosci 2000; 20: 8868-8875.
2. Lambrecht G. Design and pharmacology of selective P2-purinoceptor antagonists. J Auton Pharmacol 1996; 16: 341-344.
3. Burnstock G. Current status of purinergic signaling in the nervous system. Prog Brain Res 1999; 120: 3-10.
4. Hiruma H, Bourque CW. P2 purinoceptor-mediated depolarization of rat supraoptic neurosecretory cells in vitro. J Physiol 1995; 489: 805-811.
5. Shibuya I, Tanaka K, Hattori Y, Uezono Y, Harayama N, Noguchi J, Ueta Y, Izumi F, Yamashita H. Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones. J Physiol (Lond) 1999; 514: 351-367.
6. Jacobson KA, Hoffman C, Kim Y-C, Camaioni E, Nandanan E, Jang SY, Guo D-P, Ji X-D, von Kugelgen I, Moro S, Ziganshin AU, Rychkov A, King BF, Brown SG, Wildman SS, Burnstock G, Boyer JL, Mohanram A, Harden TK. Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis. Prog Brain Res 1999; 120: 119-132.
7. 2X2 purinoceptor. J Physiol 1998; 511: 89-103.
8. Ponzio TA, Hatton GI. Activation of presynaptic P2X receptors causes glutamate and GABA release in the supraoptic nucleus. Soc Neurosci Abstract Viewer 2004; 422: 4.
9. 2X2 receptor immunoreactivity in the rat hypothalamo-neurohypophysial system. J Neurocytol 1999; 28: 495-504.
10. Armstrong WE, Gallagher MJ, Sladek CD. Noradrenergic stimulation of supraoptic neuronal activity and vasopressin release in vitro: Mediation by an alpha-1-receptor. Brain Res 1986; 365: 192-197.
11. Randle JCR, Bourque CW, Renaud LP. α1-adrenergic receptor activation depolarizes rat supraoptic neurosecretory neurons in vitro. Am J Physiol 1986; 251: R569-R574.
12. Yamashita H, Inenaga K, Kannan H. Depolarizing effect of noradrenaline on neurons of the rat supraoptic nucleus in vitro. Brain Res 1987; 405: 348-352.
13. Acosta-Martinez M, Fiber JM, Brown RD, Etgen AM. Localization of alpha1b-adrenergic receptor in female rat brain regions involved in stress and neuroendocrine function. Neurochem Int 1999; 35: 383-391.
14. McNeill TH, Sladek JR Jr. Simultaneous monoamine histofluorescence and neuropeptide immuncytochemistry. II. Correlative distribution of catecholamine varicosities and magnocellular neurosecretory neurons in rat supraoptic and paraventricular nuclei. J Comp Neurol 1980; 193: 1023-1033.
15. Sawchenko P, Swanson LW. Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science 1981; 214: 685-687.
16. Shioda S, Nakai Y. Noradrenergic innervation of vasopressin-containing neurons in the rat hypothalamic supraoptic nucleus. Neurosci Lett 1992; 140: 215-218.
17. 2+ signaling pathway. Neuroscience Lett 1997; 226: 210-212.
18. Daftary SS, Boudaba C, Szabo K, Tasker JG. Noradrenergic excitation of magnocellular neurons in the rat hypothalamic paraventricular nucleus via intranuclear glutamatergic circuits. J Neurosci 1998; 18: 10619-10628.
19. Boudaba CS, Tasker JG. Presynaptic noradrenergic regulation of glutamate inputs to hypothalamic magnocellular neurones. J Neuroendocrinol 2003; 15: 803-810.
20. Boudaba C, Schrader LA, Tasker JG. Physiological evidence for local excitatory synaptic circuits in the rat hypothalamus. J Neurophysiol 1997; 77: 3396-3400.
21. DeSouza EB, Kuyatt BL. α1-Adrenergic receptors in the neural lobe of the rat pituitary. Autoradiographic identification and localization. Endocrinology 1987; 120: 2227-2233.
22. Garten LL, Sofroniew MV, Dyball REJ. A direct catecholaminergic projection from the brainstem to the neurohypophysis of the rat. Neuroscience 1989; 33: 149-155.
23. Alper RH, Demarest KT, Moore KE. Effects of surgical sympathectomy on catecholamine concentrations in the posterior pituitary of the rat. Experientia 1980; 36: 134-135.
24. Saavedra JM. Central and peripheral catecholamine innervation of the rat intermediate and posterior pituitary lobes. Neuroendocrinology 1985; 40: 281-284.
25. Sladek CD, Fisher KY, Sidorowicz HE, Mathiasen JR. Osmotic stimulation of vasopressin mRNA content in the supraoptic nucleus requires synaptic activation. Am J Physiol 1995; 268: R1034-R1039.
26. Gordon GRJ, Bains JS. Priming of excitatory synapses by α1-adrenoceptor-mediated inhibition of group III metabotropic glutamate receptors. J Neurosci 2003; 23: 6223-6231.
27. Gordon GRJ, Baimoukhametova DV, Hewitt SA, Kosala WRA, Rajapaksha JS, Fisher TE, Bains JS. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nature Neurosci 2005; 8: 1078-1086.
28. Van den Pol AN, Waurin JP, Dudek FE. Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. Science 1990; 250: 1276-1278.
29. Sladek CD, Armstrong WE. GABA antagonists stimulate vasopressin release from organ-cultured hypothalamo-neurohypophyseal explants. Endocrinology 1987; 120: 1576-1580.
30. Chen Z-P, Levy A, Lightman SL. Nucleotides as extracellular signaling molecules. J Neuroendocrinol 1995; 7: 83-96.
31. 1-Adrenergic receptor subtypes: Molecular structure, function and signaling. Circ Res 1996; 78: 737-749.
32. Stocker SD, Schiltz JC, Sved AF. Acute increases in arterial blood pressure do not reduce plasma vasopressin levels stimulated by angiotensin II or hyperosmolality in rats. Am J Physiol Regul Integr Comp Physiol 2004; 287: R127-R137.